This condition could constitute the breeding ground for the evolution of prostate cancer towards a more aggressive form (G9), involving a change in SHMT2 and PKM2 status through the IL-6/JAK2/STAT3 pathway. This evidence concerns the gene SHMT2 and prostate cancer.